646
Views
13
CrossRef citations to date
0
Altmetric
Research Papers

Determinants of influenza vaccination among solid organ transplant recipients attending Sicilian reference center

, , , , &

ABSTRACT

Among solid organ transplant recipients, influenza infection is commonly associated with higher morbidity and mortality than immunocompetent hosts. Therefore, in these subjects influenza vaccination is of paramount importance. The main objective of the study was to assess compliance to vaccination and analyze factors associated with influenza vaccination of solid organ transplant recipients admitted to the Sicilian solid organ transplant Reference Center IRCCS-ISMETT in Palermo during 2014–2015 influenza season. Thirty one (37.8%) out of 82 solid organ transplant recipients were vaccinated against influenza. The main reason for vaccination refusal was fear of adverse reaction (n = 16, 31.4%), impaired health status (n = 14, 27.4%) and low vaccine efficacy (n = 10, 19.6%). Vaccinated solid organ transplant recipients compare with unvaccinated had smaller hospital admissions for infectious respiratory diseases (9.7% Vs 23.5%) during surveillance period. On multivariate analysis the factors positively associated with influenza vaccination were the advice of Reference Center physicians (OR 53.4, p < 0.001) and to perform vaccine against pneumococcus (OR 7.0, p = 0.016). This study showed that Reference Center physicians play a key role on vaccine communication and recommendation for patients at risk and it underlines the effectiveness of influenza vaccination in solid organ transplant recipients. However, it remains that, although physician advice resulted a strong determinant for vaccination, influenza vaccination coverage in this subset of population remains still unsatisfactory.

Introduction

Influenza is a considerable public health issue due to its dissemination and contagiousness, causing annually 3 to 5 million cases of severe illness and 1 million deaths worldwide.Citation1 This disease is more serious in hospital setting, where healthcare workers are at increased risk of influenza, both for exposure to infected patients and viruses present outdoor.Citation2 Indeed, influenza attack rate varies between 5–10% in general population whereas 11–59% in healthcare workers who take care of patients with ILI.Citation3 Because influenza is more severe among patients with chronic diseases National Health Authorities identified at risk groups, including SOT recipients, to which recommend anti-influenza and anti-pneumococcal vaccination.Citation4,5,6,7 In particular IDSA guidelines counselled to administer inactivated influenza vaccine since one month after transplantation during community influenza outbreak.Citation8 Indeed influenza is even more common among SOT recipient as showed in a 10-year longitudinal study with an incidence of 4.3 cases per 1,000 person years.Citation9 In addition to complications (pneumonia and low airways infections) of general population, influenza can cause transplant rejection in SOT recipients.Citation9 Despite wide dissemination of guidelines among healthcare workers, vaccination against influenza is not yet standard practice in transplant centers. According to Dinits-Pensy et al.Citation10 many nephrological practices are reluctant to administer vaccines, partly due to a lack of understanding regarding their risk/benefit ratio. Slightly different results were found among heart transplant centers. Of the 28 transplant centers investigated in a multicenter study by White-Williams et al.Citation11 25 recommended influenza vaccination. The remaining 3 centers did not recommend influenza vaccination because of a supposed association with allograft rejection. Furthermore, little is known about predictors of vaccine uptake in SOT recipients. With the exception of Berben et al.Citation12 that founded positive vaccination status significantly related to older age in a population of kidney transplant recipients.

The main objective of study was to analyze vaccination uptake and its determinants among SOT recipients to implement immunization adherence in a population at higher risk of influenza complications.

Result

A total of 82 SOT recipients were enrolled during the study period. shows demographic and clinical characteristics of patients. Overall, the mean age was 50 y (CI 47–52), employed were more represented (48.8%) followed by retired from work (37.8%) and males were more recurring than females (73.2% Vs. 26.8%). Only 31 out of 82 (37.8%) performed vaccination against-influenza. More than half of SOT recipients (57.3%) declared to have not suffered from ILI during 3 previous influenza seasons. Moreover seventeen patients (20.7%) received anti-pneumococcal vaccination. The most frequently graft performed was liver (41.5%) followed by lung (26.8%) and kidney (18.3%). SOT recipients resulted suffering more from cardiovascular diseases (73.2%) followed by chronic hepatitis (37.8%) and chronic renal failure (30.5%).

Table 1. Demographics and clinical characteristics of SOT recipients attending RC during 2014–2015 influenza season.

Those who performed anti-influenza vaccination were older (53.6 Vs 47.5 years, respectively; p = 0.063), and more frequently retired from work than non-vaccinated ones (58.1% Vs 41.9%). On the other hand unvaccinated SOT patients were more recurrent than vaccinated employed (80.0% Vs. 20%) and unemployed (54.5% Vs 45.5%; p = 0.004). Furthermore, who suffered from ILI during the 3 previous seasons investigated, were significantly more resistant to anti-influenza vaccination (77.2% Vs 22.8%; p = 0.016). Comparing vaccinated with unvaccinated SOT recipients the main source of information in support of vaccination was RC physician (84.2% Vs. 15.8%), whereas General Practitioner (41.4% Vs. 58.6%) and other physician (20% Vs. 80%) resulted less effective (p = 0.022). The type of graft and medical history did not seem to influence the choice to be vaccinated against influenza among SOT recipients.

All factors significantly associated with anti-influenza vaccination adherence on bivariate analysis were included in a multivariate logistic analysis (). Supporting anti-influenza vaccination by RC physician (OR of 53.4; p < 0.001), followed by have been previously vaccinated against pneumococcus (OR 7.0; p = 0.016) were the main positively determinants of influenza vaccination among SOT recipients.

Table 2. Multivariate analysis of factors associated with influenza vaccine uptake among SOT recipients during 2014–2015 influenza season.

shows the causes of missed influenza immunization by SOT recipients. Among these, the fear of adverse reactions (31.4%) followed by health status (27.4%) and low vaccine efficacy (19.6%) played a major role.

Figure 1. Reasons for missed vaccination in SOT recipients.

Figure 1. Reasons for missed vaccination in SOT recipients.

shows the effectiveness of influenza vaccination analyzing the number of SOT recipients with at least one admission for respiratory diseases in season 2014–2015. Those who were not vaccinated had greater percentage of hospitalizations for respiratory disease compare with vaccinated (23.2% Vs. 9.7%; p = 0.116).

Figure 2. Following hospitalizations for respiratory disease among SOT recipients with or without performing anti-influenza vaccine during 2014–2015 influenza season.

Figure 2. Following hospitalizations for respiratory disease among SOT recipients with or without performing anti-influenza vaccine during 2014–2015 influenza season.

Discussion

This study analyzes the determinants of anti-influenza vaccination in a major “at risk” category as SOT recipients. Vaccination coverage in 2014–2015 season, in Italy, showed a slight decrease, with respect to previous season, both among general population (13.6%) and at risk categories like over 65 (48.6%).Citation13 In our series, observed values were lower in comparison with those reported by other studies conducted in SOT recipients.Citation14,15

Overall, the key determinant for anti-influenza vaccination uptake was information provided by RC physician. According to our data, the suggestion of RC physician weighted more than General Practitioner, parents/friends and other sources. This could be explained by the general persuasion about more specific awareness of specialists about vaccine recommendations in this specific population.Citation14 This result makes us reflect on the need for continuous updating of physician especially those treating critical subjects as also suggested by our group in a previous paper about up to date knowledge on influenza epidemiology.Citation16

Another factor positively associated with anti-influenza vaccination uptake among study population was to have had a previous experience of anti-pneumococcal vaccination (OR = 7.0; p = 0.016). The finding that, in adult population, a favorable opinion toward vaccination in general was associated with previous vaccination uptake of specific vaccines (influenza and pneumococcal) is worthy of interest. Similarly, Nichol et al.Citation17 also founded that positive attitudes toward immunization were independently associated with both influenza and pneumococcal vaccination behaviors among 700 immunocompromised adult patients.

The main reason for vaccination failure is fear of adverse events and in particular of graft rejection (data not shown in table). Because successful vaccination requires a partial activation of the immune system, doubts have been raised about a possible increase in the risk of acute rejection episodes, and thus about the safety of influenza vaccination in transplant patients.Citation11 This fear, however, has not been substantiated by scientific evidence.Citation6 Indeed rate of rejections did not increase in the months before, during, or after the administration of the influenza vaccine.Citation11 Another reason of missing vaccination was impaired state of health similarly to other studies conducted in the same area.Citation18,19 Among SOT recipients this belief can be attributed to the immunosuppressive therapy. Firstly it should be stressed that, if immunosuppressive therapy could partially decrease the immune system, it is true that to be exposed to microorganisms in real life should be much more at risk in respect of purified antigens contained in a vaccine. Subsequently, various studies have shown that SOT recipients antibody response to the influenza vaccine still significantly decreases the probability of contracting influenza.Citation20,21

Monitoring SOT recipients admission to the Sicilian RC during influenza season there were a higher probability of health services request for respiratory diseases (pneumonia and low airways infection) among unvaccinated than vaccinated patients. This observation reveals an indirect proof of anti-influenza vaccine effectiveness. Other studies have found health benefits of anti-influenza vaccine in high-risk categories.Citation6,22 Even though further research is needed to evaluate the overall risks and benefits of anti-influenza-vaccine in SOT recipients.

Although the main limitation of study was the small sample analysis, the low number of donor in the area under investigation makes relevant obtained results.Citation23 Furthermore, the possibility of a recall bias during administration of the questionnaire may have been, although the use of electronic patient records, to obtain information about SOT recipients health conditions, should have reduced this risk.

In conclusion, this study underlines the need to improve the patient-doctor relationship at a communication level, especially in high risk patients concerning efficacy and safety of vaccination. Therefore, sharing detailed scientific knowledge among RC physician and General Practitioner will improve the awareness about vaccination safety and efficacy in general population, ultimately promoting health among at risk population as SOT recipients are.

Material and methods

This study was conducted with an observational design. Patients were enrolled from 42nd week of 2014 to 16th week of 2015 at IRCCS-ISMETT in Palermo (Sicilian SOT Reference Centre), an hospital with 78 beds for acute and 7 day hospitals taking care of 5,000 patients and performing a mean of 128 transplantation each year.Citation24 All SOT recipients or patients who performed a transplantation during hospital stay were administered a structured interview. Variables included in the questionnaire examined demographic characteristics (sex, age, occupation), health (smoking habits, medical history, type of graft) and vaccination status (anti-influenza and anti-pneumococcal vaccines). To investigate the effectiveness of anti-influenza vaccination it was registered patient with a hospital admissions for respiratory diseases among SOT recipients during all influenza season. This study was approved by the Institutional Review Research Board IRCCS-ISMETT.

Statistical analysis

All data were analyzed using Stata v14.1 statistical software. For all analyses, a p-value of 0.05 was assumed to indicate significance (2-tailed). Absolute and relative frequencies have been reported for qualitative variables, and medians (IQR) have been reported for quantitative, non-normally distributed variables. Normal distribution was verified by Shapiro Wilk's test for normality, and median data were compared using the Skewness and Kurtosis test. Categorical variables were analyzed using Chi square test (Mantel-Haenszel). All variables that were found to be significantly associated (p < 0.05) with influenza vaccination receipt in bivariate analysis were included in a multivariable logistic regression model. Goodness of fit was calculated for each model, and the model with the lowest Akaike Information Criterion was considered to have the best fit. Adjusted OR and CI 95% were calculated for the variables retained in the final model.

Abbreviations

CI=

confidence intervals

IDSA=

Infectious Diseases Society of America

ILI=

influenza like illness

IQR=

interquartile range

OR=

odds ratio

RC=

reference center

SOT=

solid organ transplant

Disclosure of potential conflicts of interest

No potential conflicts of interest were disclosed.

References

  • Pearson ML, Bridges CB, Harper SA, Healthcare Infection Control Practices Advisory Committee (HICPAC).; Advisory Committee on Immunization Practices (ACIP). Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2006; 55(RR-2):1-16.
  • Amodio E, Restivo V, Firenze A, Mammina C, Tramuto F, Vitale F. Can influenza vaccination coverage among healthcare workers influence the risk of nosocomial influenza-like illness in hospitalized patients? J Hosp Infect. 2014; 86(3):182-7; PMID:24581755; http://dx.doi.org/10.1016/j.jhin.2014.01.005
  • Walker FJ, Singleton JA, Lu P, Wooten KG, Strikas RA. Influenza vaccination of healthcare workers in the United States, 1989–2002. Infect Control Hosp Epidemiol 2006; 27(3):257-65; PMID:16532413; http://dx.doi.org/10.1086/501538
  • Mauskopf J, Klesse M, Lee S, Herrera-Taracena G. The burden of influenza complications in different high-risk groups: a targeted literature review. J Med Econ 2013; 16(2):264-77; PMID:23173567; http://dx.doi.org/10.3111/13696998.2012.752376
  • Italian Ministry of Health. Prevention and control of influenza: recommendations for the 2015–2016 season. Available July 29, 2016 at http://www.trovanorme.salute.gov.it/norme/renderNormsanPdf?anno = 2015&codLeg = 52703&parte = 1%20&serie=
  • Danziger-Isakov L, Kumar D. AST infectious diseases community of practice. Vaccination in solid organ transplantation. Am J Transplant 2013; 13 Suppl 4:311-7; http://dx.doi.org/10.1111/ajt.12122
  • Italian Ministry of Health. National vaccination plan 2012–2014. Available August 02, 2016 at: http://www.salute.gov.it/imgs/c_17_pubblicazioni_1721_allegato.pdf
  • Rubin LG, Levin MJ, Ljungman P, Davies EG, Avery R, Tomblyn M, Bousvaros A, Dhanireddy S, Sung L, Keyserling H et al. 2013 IDSA clinical practice guideline for vaccination of the immunocompromised host. Clin Infect Dis 2014; 58:e44; PMID:24311479; http://dx.doi.org/10.1093/cid/cit684
  • Vilchez RA, McCurry K, Dauber J, Lacono A, Griffith B, Fung J, Kusne S. Influenza virus infection in adult solid organ transplant recipients. Am J Transplant 2002; 2:287; PMID:12096793; http://dx.doi.org/10.1034/j.1600-6143.2002.20315.x
  • Dinits-Pensy M, Forrest GN, Cross AS, Hise MK. The use of vaccines in adult patients with renal disease. Am J Kidney Dis 2005; 46(6):997-1011; PMID:16310566; http://dx.doi.org/10.1053/j.ajkd.2005.08.032
  • White-Williams C, Brown R, Kirklin J, St Clair K, Keck S, O'Donnell J, Pitts D, Van Bakel A. Improving clinical practice: should we give influenza vaccinations to heart transplant patients? J Heart Lung Transplant 2006; 25(3):320-323; PMID:16507426; http://dx.doi.org/10.1016/j.healun.2005.09.015
  • Berben L, Denhaerynck K, Schaub S, De Geest S. Prevalence and correlates of influenza vaccination among kidney transplant patients. Prog Transplant 2009; 19(4):312-7; PMID:20050453; http://dx.doi.org/10.7182/prtr.19.4.fh68723655737441
  • Italian Ministry of Health. Anti-influenza vaccination coverage. Available on July 28, 2016 at http://www.salute.gov.it/imgs/C_17_tavole_19_allegati_iitemAllegati_15_fileAllegati_itemFile_1_file.pdf
  • Loubet P, Kernéis S, Groh M, Loulergue P, Blanche P, Verger P, Launay O. Attitude, knowledge and factors associated with influenza and pneumococcal vaccine uptake in a large cohort of patients with secondary immune deficiency. Vaccine 2015; 33(31):3703; http://dx.doi.org/10.1016/j.vaccine.2015.06.012
  • Pebody RG, Hippisley-Cox J, Harcourt S, Pringle M, Painter M, Smith G. Uptake of pneumococcal polysaccharide vaccine in at-risk populations in England and Wales 1999–2005. Epidemiol Infect 2008; 136(3):360-9; PMID:17445314; http://dx.doi.org/10.1017/S0950268807008436
  • Amodio E, Tramuto F, Costantino C, Restivo V, Maida C, Calamusa G, Vitale F. Diagnosis of influenza: only a problem of coding? Med Princ Pract 2014; 23(6):568-73; PMID:25059566; http://dx.doi.org/10.1159/000364780
  • Nichol KL, Mac Donald R, Hauge M. Factors associated with influenza and pneumococcal vaccination behaviour among high-risk adults. J Gen Intern Med 1996; 11(11):673-7; PMID:9120653; http://dx.doi.org/10.1007/BF02600158
  • Firenze A, Marsala MG, Bonanno V, Maranto M, Ferrara C, Giovannelli L, Restivo V. Facilitators and barriers HPV unvaccinated girls after 5 years of program implementation. Hum Vaccin Immunother 2015; 11(1):240-4; PMID:25483543; http://dx.doi.org/10.4161/hv.36158
  • Restivo V, Napoli G, Marsala MG, Bonanno V, Sciuto V, Amodio E, Calamusa G, Vitale F, Firenze A. Factors associated with poor adherence to MMR vaccination in parents who follow vaccination schedule. Hum Vaccin Immunother 2015; 11(1):140-5; PMID:25483527; http://dx.doi.org/10.4161/hv.34416
  • Wyzgal J, Brydak LB, Zygier D, Paczek L, Rowinski W, Grochowiecki T. Study on efficacy of influenza vaccination in renal allograft recipients. Transplant Proc 2002; 34(2):572-575; PMID:12009628; http://dx.doi.org/10.1016/S0041-1345(01)02849-4
  • Cavdar C, Sayan M, Sifil A, Artuk C, Yilmaz N, Bahar H, Camsari T. The comparison of antibody response to influenza vaccination in continuous ambulatory peritoneal dialysis, hemodialysis and renal transplantation patients. Scand J Urol Nephrol 2003; 37(1):71-76; PMID:12745749; http://dx.doi.org/10.1080/00365590310008749
  • Perez-Romero P, Aydillo TA, Perez-Ordoñez A, Muñoz P, Moreno A, López-Medrano F, Bodro M, Montejo M, Gavaldà J, Fariñas MC et al. Reduced incidence of pneumonia in influenza-vaccinated solid organ transplant recipients with influenza disease. Clin Microbiol Infect 2012; 18(12):E533-40; PMID:23078072; http://dx.doi.org/10.1111/1469-0691.12044
  • Italian Transplantation Centre. Activity data for 2015. Available August 02, 2016 at: http://www.trapianti.salute.gov.it/cnt/cntPrimoPianoDett.jsp?area = cnt-generale&menu = menuPrincipale&id = 373
  • IRCCS-ISMETT. Report about main activity data of IRCCS-ISMETT. Available on July 27, 2016 at: http://www.ismett.edu/?q = it/system/files/Relazione-dati-ISMETT_new2_0.pdf

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.